Harel Insurance Investments & Financial Services’s Lifestance Health LFST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-1,532
Closed -$8K 536
2024
Q2
$8K Buy
1,532
+80
+6% +$482 ﹤0.01% 492
2024
Q1
$9K Sell
1,452
-796
-35% -$5.36K ﹤0.01% 495
2023
Q4
$18K Sell
2,248
-4,036
-64% -$26K ﹤0.01% 501
2023
Q3
$43K Sell
6,284
-54
-0.9% -$438 ﹤0.01% 477
2023
Q2
$58K Buy
6,338
+157
+3% +$1.3K ﹤0.01% 460
2023
Q1
$46K Buy
6,181
+273
+5% +$1.51K ﹤0.01% 498
2022
Q4
$29K Sell
5,908
-19
-0.3% -$117 ﹤0.01% 546
2022
Q3
$43K Sell
5,927
-811
-12% -$5.66K ﹤0.01% 528
2022
Q2
$37K Buy
+6,738
New +$51.6K ﹤0.01% 554
2022
Q1
Sell
-8,904
Closed -$85K 769
2021
Q4
$85K Buy
+8,904
New +$94.4K ﹤0.01% 522

Other funds holding LFST

Harel Insurance Investments & Financial Services's LFST Position: Q3 2024 in Review

Harel Insurance Investments & Financial Services sold out of Lifestance Health (LFST) in Q3 2024, closing a stake of 1,532 shares — an estimated $8K sold.

Harel Insurance Investments & Financial Services first reported a position in LFST in Q4 2021 and held it in 10 quarters. The position peaked at $85K in Q4 2021. 130 funds tracked by Wall St. Rank hold LFST as of Q3 2024.

  • Harel Insurance Investments & Financial Services reported no remaining Lifestance Health position as of Q3 2024 after selling out during the quarter.
  • Harel Insurance Investments & Financial Services sold 1,532 Lifestance Health shares in Q3 2024, an estimated $8K.
  • Harel Insurance Investments & Financial Services first reported a position in Lifestance Health in Q4 2021 and held it in 10 quarters.
  • Harel Insurance Investments & Financial Services's Lifestance Health position peaked at $85K in Q4 2021.
  • 130 funds tracked by Wall St. Rank held Lifestance Health as of Q3 2024.

Based on Harel Insurance Investments & Financial Services's 13F filing for Q3 2024, filed 15 Oct 2024.